Biomarker testing in non-small cell lung cancer is underutilized, hindering optimal treatment. Streamlined processes and ...

Everyone would like a cure for Alzheimer’s and other forms of dementia, but a savvy society is one ready for the continued ...

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for reflexive ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Founded in 2017by CEO Hooman Lee (trained in Convergence at Seoul National University; former researcher at ETRI), EXOSYSTEMS is venture-backed (Kakao Ventures, SBI Investment, Laguna Investment, ...

The Prognostic Lung Fibrosis Consortium (PROLIFIC), a collaborative consortium advancing biomarker tools for pulmonary ...

Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal ...

Objective This study aimed to examine whether biomarker tests—finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)—are acceptable and feasible as a guide to treatment decisions, ...

"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...